Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krupski

Showing results (371-380 of 393) with videos related to

Pageof 40
Sort By:
Bone Marrow Transplantation|April 11, 2020
CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II studyPooja Khandelwal, Tsuyoshi Fukuda, Ashley Teusink-Cross, et al.
Urologic Oncology|December 23, 2020
Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trialDonna L Berry, Fangxin Hong, Traci M Blonquist, et al.
BJU International|January 28, 2015
The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial updateNorm D Smith, Erik P Castle, Mark L Gonzalgo, et al.
The Journal of Urology|April 10, 2020
Health Related Quality of Life of Patients with Bladder Cancer in the RAZOR Trial: A Multi-Institutional Randomized Trial Comparing Robot versus Open Radical CystectomyMaria F Becerra, Vivek Venkatramani, Isildinha M Reis, et al.
Eclinicalmedicine|November 13, 2023
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patternsValentin Barsan, Yimei Li, Snehit Prabhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2017
Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized StudyNeal D Shore, Stephen A Boorjian, Daniel J Canter, et al.
Transplantation and Cellular Therapy|February 13, 2022
Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact OutcomesMalika Kapadia, Leslie Lehmann, Jeffery Auletta, et al.
The New England Journal of Medicine|May 10, 2002
Immediate repair compared with surveillance of small abdominal aortic aneurysmsFrank A Lederle, Samuel E Wilson, Gary R Johnson, et al.
Blood Advances|August 8, 2022
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortiumHeather E Stefanski, Anne Eaton, Christina Baggott, et al.
Blood Advances|April 12, 2023
Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCTAshley V Geerlinks, Brooks Scull, Christa Krupski, et al.
Pageof 40

Showing results (371-380 of 393) with videos related to

Sort By:
Pageof 40
Bone Marrow Transplantation|April 11, 2020
CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II studyPooja Khandelwal, Tsuyoshi Fukuda, Ashley Teusink-Cross, et al.
Urologic Oncology|December 23, 2020
Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trialDonna L Berry, Fangxin Hong, Traci M Blonquist, et al.
BJU International|January 28, 2015
The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial updateNorm D Smith, Erik P Castle, Mark L Gonzalgo, et al.
The Journal of Urology|April 10, 2020
Health Related Quality of Life of Patients with Bladder Cancer in the RAZOR Trial: A Multi-Institutional Randomized Trial Comparing Robot versus Open Radical CystectomyMaria F Becerra, Vivek Venkatramani, Isildinha M Reis, et al.
Eclinicalmedicine|November 13, 2023
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patternsValentin Barsan, Yimei Li, Snehit Prabhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2017
Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized StudyNeal D Shore, Stephen A Boorjian, Daniel J Canter, et al.
Transplantation and Cellular Therapy|February 13, 2022
Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact OutcomesMalika Kapadia, Leslie Lehmann, Jeffery Auletta, et al.
The New England Journal of Medicine|May 10, 2002
Immediate repair compared with surveillance of small abdominal aortic aneurysmsFrank A Lederle, Samuel E Wilson, Gary R Johnson, et al.
Blood Advances|August 8, 2022
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortiumHeather E Stefanski, Anne Eaton, Christina Baggott, et al.
Blood Advances|April 12, 2023
Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCTAshley V Geerlinks, Brooks Scull, Christa Krupski, et al.
Pageof 40